Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

O-1812

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
O-1812
Identifiers
  • (5Z,8Z,11Z,14Z)-20-cyano-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethylicosa-5,8,11,14-tetraenamide
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC26H42N2O2
Molar mass414.634 g·mol−1
3D model (JSmol)
  • C[C@H](CO)NC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C(C)(C)CCCCC#N
  • InChI=1S/C26H42N2O2/c1-24(23-29)28-25(30)19-15-12-10-8-6-4-5-7-9-11-13-16-20-26(2,3)21-17-14-18-22-27/h4-5,8-11,16,20,24,29H,6-7,12-15,17-19,21,23H2,1-3H3,(H,28,30)/b5-4-,10-8-,11-9-,20-16-/t24-/m1/s1 ☒N
  • Key:WZQHSBKOWZOASP-QLZKPENWSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

O-1812 is aneicosanoid derivative related toanandamide that acts as a potent and highly selectiveagonist for thecannabinoid receptorCB1, with aKi of 3.4 nM at CB1 and 3870 nM atCB2.[1] Unlike most related compounds, O-1812 is metabolically stable against rapid breakdown by enzymes, and produces a cannabinoid-like discriminative effect in rats, which is similar but not identical to that produced by cannabinoid drugs of other chemical classes.[2][3][4][5]

See also

[edit]

References

[edit]
  1. ^Di Marzo V, et al. (February 2001). "Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands".Biochemical and Biophysical Research Communications.281 (2):444–51.doi:10.1006/bbrc.2001.4354.PMID 11181068.
  2. ^Baskfield CY, Martin BR, Wiley JL (April 2004). "Differential effects of Δ9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice".The Journal of Pharmacology and Experimental Therapeutics.309 (1):86–91.doi:10.1124/jpet.103.055376.PMID 14718593.S2CID 36621393.
  3. ^Wiley JL, et al. (August 2004). "A comparison of the discriminative stimulus effects of Δ9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats".Experimental and Clinical Psychopharmacology.12 (3):173–9.doi:10.1037/1064-1297.12.3.173.PMID 15301634.
  4. ^Wiley JL, Smith FL, Razdan RK, Dewey WL (March 2005). "Task specificity of cross-tolerance between Δ9-tetrahydrocannabinol and anandamide analogs in mice".European Journal of Pharmacology.510 (1–2):59–68.doi:10.1016/j.ejphar.2005.01.006.PMID 15740725.
  5. ^Breivogel CS, et al. (July 2008)."Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in β-arrestin2 -/- mice".Behavioural Pharmacology.19 (4):298–307.doi:10.1097/FBP.0b013e328308f1e6.PMC 2751575.PMID 18622177.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-3-tetrahydrocannabinols
Delta-4-tetrahydrocannabinols
Delta-7-tetrahydrocannabinols
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Delta-11-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)


Stub icon

This article about analkene is astub. You can help Wikipedia byadding missing information.

Stub icon

Thiscannabinoid related article is astub. You can help Wikipedia byadding missing information.

Retrieved from "https://en.wikipedia.org/w/index.php?title=O-1812&oldid=1268767723"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2026 Movatter.jp